Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD403 for Prevention of CINV
NCT01857232Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Oct 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amisulpride in chemotherapy-induced nausea and vomiting (CINV), sponsored by Acacia Pharma Group Plc. Started Oct 2013; status: completed.
02
Drugs
amisulpride
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01857232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857232.